← All trials
NCT07049952
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 16, 2025
- Primary completion
- Apr 1, 2027
- Completion date
- Dec 30, 2027
- First posted
- Jul 3, 2025
- Last posted
- Nov 21, 2025
- Enrollment
- 88
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Medical University of South CarolinaLead sponsor
- Medical University of South CarolinaOfficial
- National Institutes of Health (NIH)Collaborator
- Medical University of South CarolinaSponsor investigator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.